SILO vs ZION · rev $18.0K vs P/E 11, rev $354.0M
Silo Pharma Inc (SILO) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
SILO currently screens at market cap $4.4M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the SILO and ZION stock pages for the full models.
Not investment advice.